Caries Detection With Two Different Caries Detecting Devices
Launched by TUFTS UNIVERSITY · Nov 21, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different tools, the LumiCare™ rinse and QLF, to see which one is better at detecting dental cavities (also known as caries). The researchers want to find out how well these devices can track the progression of cavities in patients, especially comparing those who use e-cigarettes or vapes to those who do not.
To participate in this study, you must be an adult over 21 years old who has been identified as having a high risk for cavities. You should have at least two early signs of cavities on your teeth, as well as one tooth with a more serious cavity. Participants will also need to provide recent dental X-rays showing their teeth. While the study is open to all genders, if you smoke traditional cigarettes or use smokeless tobacco, you won’t be eligible. If you join the trial, you will help researchers learn more about how to better detect and manage cavities, which can lead to healthier teeth in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients of TUSDM Comprehensive Care Clinic
- • Adult patients over the age of 21
- • Extreme/High Caries Risk classification per TUSDM Caries Management by Risk Assessment (CAMBRA) form
- • Presence of 2 or more initial active primary carious lesions on a free coronal surface of any tooth by visual assessment, QLF, and LumiCare™
- • Presence of at least 1 cavitated lesion
- • Updated (no more than 6 months old) bite wing radiographs available.
- • Patients who responded either yes/no to use of e-cigarettes/vapes
- • 1 active caries, 1 inactive caries and 1 sound tooth surface.
- Exclusion Criteria:
- • Low or moderate caries risk classification per TUSDM CAMBRA form
- • No clinically detectable carious lesions on free coronal surfaces
- • No cavitated caries lesions
- • Carious teeth with caries lesions concomitant with extrinsic stains, fluorosis, or developmental defects.
- • Patients who responded yes to the use of conventional cigarettes or smokeless tobacco
About Tufts University
Tufts University is a prestigious research institution renowned for its commitment to advancing health and medicine through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Tufts leverages its expertise in biomedical research, public health, and clinical practice to design and conduct rigorous studies that address critical health challenges. The university's clinical trial programs are characterized by their adherence to high ethical standards and regulatory compliance, ensuring the safety and well-being of participants while contributing valuable insights to the scientific community. Through its dedication to fostering education and research, Tufts University plays a vital role in translating findings into effective health interventions and policies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Karina Irusa, BDS, MS
Principal Investigator
Tufts University School of Dental Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported